Literature DB >> 32282249

Preventing Atrial Fibrillation With Treatments for Diabetes Mellitus.

Christopher B Granger1, Kenneth W Mahaffey2.   

Abstract

Entities:  

Keywords:  Editorials; atrial fibrillation; diabetes mellitus, type 2; heart failure; sodium-glucose cotransporter 2 inhibitors

Mesh：

Substances：

Year:  2020        PMID： 32282249     DOI： 10.1161/CIRCULATIONAHA.120.045864

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  3 in total

Review 1.  SGLT2 Inhibitors and Their Antiarrhythmic Properties.

Authors:  Ewald Kolesnik; Daniel Scherr; Ursula Rohrer; Martin Benedikt; Martin Manninger; Harald Sourij; Dirk von Lewinski
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

Review 2.  Antiarrhythmic effects and mechanisms of sodium-glucose cotransporter 2 inhibitors: A mini review.

Authors:  Jinchun Wu; Yanmin Liu; Xiaojuan Wei; Xiaofei Zhang; Yi Ye; Wei Li; Xiaoling Su
Journal:  Front Cardiovasc Med       Date:  2022-08-08

Review 3.  Implications of SGLT Inhibition on Redox Signalling in Atrial Fibrillation.

Authors:  David Bode; Lukas Semmler; Christian U Oeing; Alessio Alogna; Gabriele G Schiattarella; Burkert M Pieske; Frank R Heinzel; Felix Hohendanner
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.